{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:11:56Z","timestamp":1788786716066,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4016-3","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T13:04:51Z","timestamp":1517835891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Jonathan S.","family":"Zager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Gastman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sancy","family":"Leachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene C.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonhan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle R.","family":"Covington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Meldi-Plasseraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Middlebrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis H.","family":"Kaminester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Greisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah I.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee D.","family":"Cranmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Vetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Delman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"4016_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330.","DOI":"10.3322\/caac.21442"},{"key":"4016_CR2","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"4016_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599\u2013609.","journal-title":"N Engl J Med"},{"key":"4016_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307\u201317.","journal-title":"N Engl J Med"},{"key":"4016_CR5","doi-asserted-by":"crossref","unstructured":"Shaikh WR, Dusza SW, Weinstock MA, et al. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. J Natl Cancer Inst. 2016;108","DOI":"10.1093\/jnci\/djv294"},{"key":"4016_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","volume":"76","author":"SM Landow","year":"2017","unstructured":"Landow SM, Gjelsvik A, Weinstock MA. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992\u20132013. J Am Acad Dermatol. 2017;76:258\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"4016_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/jid.2014.452","volume":"135","author":"DC Whiteman","year":"2015","unstructured":"Whiteman DC, Baade PD, Olsen CM. More people die from thin melanomas (1\u00a0mm) than from thick melanomas (>4\u00a0mm) in Queensland, Australia. J Invest Dermatol. 2015;135:1190\u20133.","journal-title":"J Invest Dermatol"},{"key":"4016_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.6004\/jnccn.2016.0051","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, et al. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2016;14:450\u201373.","journal-title":"J Natl Compr Cancer Netw"},{"key":"4016_CR9","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817\u201326.","journal-title":"N Engl J Med"},{"key":"4016_CR10","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","volume":"119","author":"MD Onken","year":"2012","unstructured":"Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119:1596\u2013603.","journal-title":"Ophthalmology"},{"key":"4016_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.breast.2004.12.008","volume":"15","author":"NM Malara","year":"2006","unstructured":"Malara NM, Leotta A, Sidoti A, et al. Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas. Breast. 2006;15:81\u20139.","journal-title":"Breast"},{"key":"4016_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","volume":"72","author":"P Gerami","year":"2015","unstructured":"Gerami P, Cook RW, Russell MC, et al. Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. J Am Acad Dermatol. 2015;72:780\u20135. e783","journal-title":"J Am Acad Dermatol"},{"key":"4016_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","volume":"21","author":"P Gerami","year":"2015","unstructured":"Gerami P, Cook RW, Wilkinson J, et al. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res. 2015;21:175\u201383.","journal-title":"Clin Cancer Res"},{"key":"4016_CR14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ van de Vijver","year":"2002","unstructured":"van de Vijver MJ, He YD, van\u2019t Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999\u20132009.","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2011.0138","volume":"9","author":"PF Engstrom","year":"2011","unstructured":"Engstrom PF, Bloom MG, Demetri GD, et al. NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement. J Natl Compr Cancer Netw. 2011;9(Suppl 6):S1\u201316.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"Suppl 5","key":"4016_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2011.0137","volume":"9","author":"PG Febbo","year":"2011","unstructured":"Febbo PG, Ladanyi M, Aldape KD, et al. NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Cancer Netw. 2011;9(Suppl 5):S1\u201332. quiz S33","journal-title":"J Natl Compr Cancer Netw"},{"key":"4016_CR17","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/jnci\/djp335","volume":"101","author":"RM Simon","year":"2009","unstructured":"Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst. 2009;101:1446\u201352.","journal-title":"J Natl Cancer Inst"},{"key":"4016_CR18","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","volume":"375","author":"AM Eggermont","year":"2016","unstructured":"Eggermont AM, Chiarion-Sileni V, Grob JJ, et al. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy. N Engl J Med. 2016;375:1845\u201355.","journal-title":"N Engl J Med"},{"key":"4016_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-017-0520-1","volume":"10","author":"EC Hsueh","year":"2017","unstructured":"Hsueh EC, DeBloom JR, Lee J, et al. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test. J Hematol Oncol. 2017;10:152.","journal-title":"J Hematol Oncol"},{"key":"4016_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.6004\/jnccn.2014.0066","volume":"12","author":"DG Coit","year":"2014","unstructured":"Coit DG, Thompson JA, Andtbacka R, et al. Melanoma, version 4.2014. J Natl Compr Cancer Netw. 2014;12:621\u20139.","journal-title":"J Natl Compr Cancer Netw"},{"key":"4016_CR21","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1200\/jco.2015.33.15_suppl.9074","volume":"33","author":"HAT Kaufman","year":"2015","unstructured":"Kaufman HAT, Nemunaitis JJ, Chesne JA, Delman KA, Spitler LE, Collichio FA, Ross MI, Zhang Y, Shilkrut M, Andtbacka RHI. Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC). J Clin Oncol. 2015;33:9074.","journal-title":"J Clin Oncol"},{"key":"4016_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas A, Hamid O, Daud A, et al. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. JAMA. 2016;315:1600\u20139.","journal-title":"JAMA"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T08:29:25Z","timestamp":1570696165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4016-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4016-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was approved, and patient consent was waived according to regulatory review requirements, as set forth in section 46.101 (b) of 45 CFR 46, by the following institutional review boards:","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JSZ, BRG, SL, RCG, MDF, ARM, DMP, JTV, JDW and PG have previously served as paid consultants to Castle Biosciences, Inc. SIE serves as a paid clinical consultant to Castle Biosciences, Inc. RWC, BM, KRC and KMP are employees of Castle Biosciences, Inc. and hold stock options. All remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"130"}}